Latest Breaking News On - Tyr pharma stock - Page 1 : comparemela.com

aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0 01 EPS

aTyr Pharma (NASDAQ:LIFE) Releases Quarterly Earnings Results, Beats Estimates By $0 01 EPS
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesAtyr pharma incRoyal bankTyr pharmaGet free reportYahoo financeTyr pharma stockTyr pharma daily

Short Interest in aTyr Pharma, Inc (NASDAQ:LIFE) Rises By 167 4%

aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]

United statesTyr pharma company profileDa davidsonCharles schwab investment management incVirtu financialRoyal bankAtyr pharma incA davidsonTyr pharmaGet free reportTyr pharma stockFire capitalCharles schwab investment managementSchwab investment managementTyr pharma companyTyr pharma daily

Short Interest in aTyr Pharma, Inc (NASDAQ:LIFE) Rises By 167 4%

aTyr Pharma, Inc. (NASDAQ:LIFE – Get Free Report) was the recipient of a significant increase in short interest in March. As of March 15th, there was short interest totalling 289,300 shares, an increase of 167.4% from the February 29th total of 108,200 shares. Based on an average daily volume of 521,200 shares, the short-interest ratio […]

United statesRoyal bankAtyr pharma incA davidsonVirtu financialCharles schwab investment management incTyr pharma company profileDa davidsonTyr pharmaGet free reportTyr pharma stockFire capitalCharles schwab investment managementSchwab investment managementTyr pharma companyTyr pharma daily

aTyr Pharma, Inc (NASDAQ:LIFE) Receives $20 75 Consensus Target Price from Analysts

aTyr Pharma, Inc (NASDAQ:LIFE) Receives $20 75 Consensus Target Price from Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

United statesVirtu financialCharles schwab investment management incCapital partnersAtyr pharma incA davidsonTyr pharmaGet free reportFire capitalSchwab investment managementTyr pharma stockGet freeTyr pharma daily

aTyr Pharma (NASDAQ:LIFE) Stock Rating Reaffirmed by HC Wainwright

HC Wainwright reissued their buy rating on shares of aTyr Pharma (NASDAQ:LIFE – Free Report) in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a $35.00 price target on the biotechnology company’s stock. Separately, StockNews.com lowered aTyr Pharma from a hold rating to a sell rating in a research […]

United statesBlackrock incAlyeska investment groupTyr pharma company profileVanguard group incSamsara biocapitalAtyr pharma incTyr pharmaFree reportModerate buyTyr pharma stockTyr pharma companyGet free reportTyr pharma dailyAtyr pharmaNasdaq life